Logo image of HMN

HORACE MANN EDUCATORS (HMN) Stock Fundamental Analysis

NYSE:HMN - New York Stock Exchange, Inc. - US4403271046 - Common Stock - Currency: USD

41.97  +0.03 (+0.07%)

After market: 41.97 0 (0%)

Fundamental Rating

4

Overall HMN gets a fundamental rating of 4 out of 10. We evaluated HMN against 143 industry peers in the Insurance industry. HMN may be in some trouble as it scores bad on both profitability and health. HMN has a decent growth rate and is not valued too expensively. HMN also has an excellent dividend rating.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

In the past year HMN was profitable.
In the past year HMN had a positive cash flow from operations.
Of the past 5 years HMN 4 years were profitable.
HMN had a positive operating cash flow in each of the past 5 years.
HMN Yearly Net Income VS EBIT VS OCF VS FCFHMN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M 300M 400M

1.2 Ratios

The Return On Assets of HMN (0.71%) is worse than 67.13% of its industry peers.
Looking at the Return On Equity, with a value of 7.98%, HMN is in line with its industry, outperforming 47.55% of the companies in the same industry.
Industry RankSector Rank
ROA 0.71%
ROE 7.98%
ROIC N/A
ROA(3y)0.34%
ROA(5y)0.6%
ROE(3y)3.86%
ROE(5y)5.39%
ROIC(3y)N/A
ROIC(5y)N/A
HMN Yearly ROA, ROE, ROICHMN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2 4 6 8 10

1.3 Margins

With a Profit Margin value of 6.47%, HMN perfoms like the industry average, outperforming 49.65% of the companies in the same industry.
HMN's Profit Margin has declined in the last couple of years.
The Operating Margin of HMN (9.80%) is comparable to the rest of the industry.
In the last couple of years the Operating Margin of HMN has declined.
Industry RankSector Rank
OM 9.8%
PM (TTM) 6.47%
GM N/A
OM growth 3Y-12.94%
OM growth 5Y-12.98%
PM growth 3Y-15.29%
PM growth 5Y-12.85%
GM growth 3YN/A
GM growth 5YN/A
HMN Yearly Profit, Operating, Gross MarginsHMN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 10 15

3

2. Health

2.1 Basic Checks

HMN does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for HMN remains at a similar level compared to 1 year ago.
Compared to 5 years ago, HMN has less shares outstanding
Compared to 1 year ago, HMN has an improved debt to assets ratio.
HMN Yearly Shares OutstandingHMN Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M
HMN Yearly Total Debt VS Total AssetsHMN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B

2.2 Solvency

HMN has a debt to FCF ratio of 1.21. This is a very positive value and a sign of high solvency as it would only need 1.21 years to pay back of all of its debts.
HMN's Debt to FCF ratio of 1.21 is in line compared to the rest of the industry. HMN outperforms 57.34% of its industry peers.
HMN has a Debt/Equity ratio of 0.42. This is a healthy value indicating a solid balance between debt and equity.
The Debt to Equity ratio of HMN (0.42) is worse than 60.84% of its industry peers.
Although HMN does not score too well on debt/equity it has very limited outstanding debt, which is well covered by the FCF. We will not put too much weight on the debt/equity number as it may be because of low equity, which could be a consequence of a share buyback program for instance. This needs to be investigated.
Industry RankSector Rank
Debt/Equity 0.42
Debt/FCF 1.21
Altman-Z N/A
ROIC/WACCN/A
WACC8.05%
HMN Yearly LT Debt VS Equity VS FCFHMN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

2.3 Liquidity

Industry RankSector Rank
Current Ratio N/A
Quick Ratio N/A
HMN Yearly Current Assets VS Current LiabilitesHMN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 5M 10M 15M

5

3. Growth

3.1 Past

HMN shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 91.62%, which is quite impressive.
HMN shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 7.81% yearly.
The Revenue has been growing slightly by 6.42% in the past year.
Measured over the past years, HMN shows a small growth in Revenue. The Revenue has been growing by 2.09% on average per year.
EPS 1Y (TTM)91.62%
EPS 3Y-3.86%
EPS 5Y7.81%
EPS Q2Q%78.33%
Revenue 1Y (TTM)6.42%
Revenue growth 3Y5.8%
Revenue growth 5Y2.09%
Sales Q2Q%7.88%

3.2 Future

The Earnings Per Share is expected to grow by 11.85% on average over the next years. This is quite good.
The Revenue is expected to grow by 4.92% on average over the next years.
EPS Next Y19.92%
EPS Next 2Y15.69%
EPS Next 3Y11.85%
EPS Next 5YN/A
Revenue Next Year6.11%
Revenue Next 2Y5.99%
Revenue Next 3Y4.92%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
HMN Yearly Revenue VS EstimatesHMN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 500M 1B 1.5B
HMN Yearly EPS VS EstimatesHMN Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 1 2 3 4

6

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 11.47, which indicates a very decent valuation of HMN.
60.84% of the companies in the same industry are more expensive than HMN, based on the Price/Earnings ratio.
Compared to an average S&P500 Price/Earnings ratio of 24.21, HMN is valued rather cheaply.
A Price/Forward Earnings ratio of 9.83 indicates a reasonable valuation of HMN.
The rest of the industry has a similar Price/Forward Earnings ratio as HMN.
HMN is valuated cheaply when we compare the Price/Forward Earnings ratio to 20.44, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 11.47
Fwd PE 9.83
HMN Price Earnings VS Forward Price EarningsHMN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

The rest of the industry has a similar Enterprise Value to EBITDA ratio as HMN.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of HMN indicates a somewhat cheap valuation: HMN is cheaper than 79.02% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 3.8
EV/EBITDA 12.26
HMN Per share dataHMN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30

4.3 Compensation for Growth

HMN's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
PEG (NY)0.58
PEG (5Y)1.47
EPS Next 2Y15.69%
EPS Next 3Y11.85%

7

5. Dividend

5.1 Amount

HMN has a Yearly Dividend Yield of 3.34%.
HMN's Dividend Yield is a higher than the industry average which is at 3.21.
HMN's Dividend Yield is a higher than the S&P500 average which is at 2.41.
Industry RankSector Rank
Dividend Yield 3.34%

5.2 History

The dividend of HMN has a limited annual growth rate of 3.32%.
HMN has paid a dividend for at least 10 years, which is a reliable track record.
HMN has not decreased their dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)3.32%
Div Incr Years14
Div Non Decr Years14
HMN Yearly Dividends per shareHMN Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.2 0.4 0.6 0.8 1

5.3 Sustainability

HMN pays out 53.99% of its income as dividend. This is a bit on the high side, but may be sustainable.
The dividend of HMN is growing, but earnings are growing more, so the dividend growth is sustainable.
DP53.99%
EPS Next 2Y15.69%
EPS Next 3Y11.85%
HMN Yearly Income VS Free CF VS DividendHMN Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M 300M 400M
HMN Dividend Payout.HMN Dividend Payout, showing the Payout Ratio.HMN Dividend Payout.PayoutRetained Earnings

HORACE MANN EDUCATORS

NYSE:HMN (5/9/2025, 8:04:00 PM)

After market: 41.97 0 (0%)

41.97

+0.03 (+0.07%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupInsurance
GICS IndustryInsurance
Earnings (Last)05-06 2025-05-06/amc
Earnings (Next)08-05 2025-08-05/amc
Inst Owners107.03%
Inst Owner Change-0.87%
Ins Owners1.4%
Ins Owner Change3.2%
Market Cap1.72B
Analysts75
Price Target45.9 (9.36%)
Short Float %1.77%
Short Ratio2.96
Dividend
Industry RankSector Rank
Dividend Yield 3.34%
Yearly Dividend1.36
Dividend Growth(5Y)3.32%
DP53.99%
Div Incr Years14
Div Non Decr Years14
Ex-Date03-17 2025-03-17 (0.35)
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)31.19%
Min EPS beat(2)4.57%
Max EPS beat(2)57.82%
EPS beat(4)3
Avg EPS beat(4)10.88%
Min EPS beat(4)-23.76%
Max EPS beat(4)57.82%
EPS beat(8)7
Avg EPS beat(8)13.97%
EPS beat(12)8
Avg EPS beat(12)12.67%
EPS beat(16)12
Avg EPS beat(16)15.43%
Revenue beat(2)0
Avg Revenue beat(2)-2.56%
Min Revenue beat(2)-3.2%
Max Revenue beat(2)-1.92%
Revenue beat(4)0
Avg Revenue beat(4)-2.9%
Min Revenue beat(4)-4.26%
Max Revenue beat(4)-1.92%
Revenue beat(8)1
Avg Revenue beat(8)-2.61%
Revenue beat(12)1
Avg Revenue beat(12)-2.44%
Revenue beat(16)3
Avg Revenue beat(16)-1.8%
PT rev (1m)0%
PT rev (3m)2.27%
EPS NQ rev (1m)-3.96%
EPS NQ rev (3m)-0.34%
EPS NY rev (1m)-0.75%
EPS NY rev (3m)1.67%
Revenue NQ rev (1m)-0.3%
Revenue NQ rev (3m)-0.34%
Revenue NY rev (1m)-1.77%
Revenue NY rev (3m)-1.55%
Valuation
Industry RankSector Rank
PE 11.47
Fwd PE 9.83
P/S 1.08
P/FCF 3.8
P/OCF 3.8
P/B 1.33
P/tB 1.6
EV/EBITDA 12.26
EPS(TTM)3.66
EY8.72%
EPS(NY)4.27
Fwd EY10.17%
FCF(TTM)11.04
FCFY26.31%
OCF(TTM)11.04
OCFY26.31%
SpS38.81
BVpS31.44
TBVpS26.31
PEG (NY)0.58
PEG (5Y)1.47
Profitability
Industry RankSector Rank
ROA 0.71%
ROE 7.98%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM 9.8%
PM (TTM) 6.47%
GM N/A
FCFM 28.44%
ROA(3y)0.34%
ROA(5y)0.6%
ROE(3y)3.86%
ROE(5y)5.39%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-12.94%
OM growth 5Y-12.98%
PM growth 3Y-15.29%
PM growth 5Y-12.85%
GM growth 3YN/A
GM growth 5YN/A
F-Score9
Asset Turnover0.11
Health
Industry RankSector Rank
Debt/Equity 0.42
Debt/FCF 1.21
Debt/EBITDA 3
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage 4.65
Cash Conversion 248.27%
Profit Quality 439.79%
Current Ratio N/A
Quick Ratio N/A
Altman-Z N/A
F-Score9
WACC8.05%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)91.62%
EPS 3Y-3.86%
EPS 5Y7.81%
EPS Q2Q%78.33%
EPS Next Y19.92%
EPS Next 2Y15.69%
EPS Next 3Y11.85%
EPS Next 5YN/A
Revenue 1Y (TTM)6.42%
Revenue growth 3Y5.8%
Revenue growth 5Y2.09%
Sales Q2Q%7.88%
Revenue Next Year6.11%
Revenue Next 2Y5.99%
Revenue Next 3Y4.92%
Revenue Next 5YN/A
EBIT growth 1Y77.94%
EBIT growth 3Y-7.88%
EBIT growth 5Y-11.16%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y49.65%
FCF growth 3Y30.19%
FCF growth 5Y28.79%
OCF growth 1Y49.65%
OCF growth 3Y30.19%
OCF growth 5Y28.79%